Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis

Identifieur interne : 001084 ( Main/Exploration ); précédent : 001083; suivant : 001085

Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis

Auteurs : Stephen D. Lawn [Royaume-Uni, États-Unis] ; Donna Rudolph [États-Unis] ; Alain Ackah [Côte d'Ivoire] ; Doulhourou Coulibaly [Côte d'Ivoire] ; Stefan Wiktor [Côte d'Ivoire] ; Renu B. Lal [États-Unis]

Source :

RBID : ISTEX:D5172770E1E1C71A139CCD6BD60DD381FCF09F1B

English descriptors

Abstract

Since expression of both interleukin-2 (IL-2) and IL-2-receptor-α (IL-2R-α) by lymphocytes is inhibited by human immunodeficiency virus (HIV) in vitro, we hypothesized that HIV-co-infection among persons with tuberculosis (TB) might impair T-lymphocyte responses to TB via this mechanism. We measured soluble IL-2R-α (sIL-2R-α), a surrogate marker of T-lymphocyte activation and proliferation, and soluble tumour necrosis factor receptor I (sTNF-RI) in sera from West African patients categorized into 4 groups: those with TB alone (TB+ HIV−, n = 55), CD4-matched groups with TB and HIV co-infection (TB+ HIV+, n = 50) or HIV infection alone (TB− HIV+, n = 35), and patients with neither disease (TB− HIV−, n = 35). The median level of sIL-2R-α was markedly greater in the TB+ HIV− group (1580 U/mL) compared to the TB− HIV− (670 U/mL; P < 0.001) and TB− HIV+ (880 U/mL; P < 0.01) groups. More importantly, the median concentration of sIL-2R-α was much lower in the TB+ HIV+ group (855 U/mL) compared to the TB+ HIV− group (1580 U/mL; P < 0.01) despite similar levels of sTNF-RI. These results suggest that T-lymphocyte activation in TB patients is impaired by HIV co-infection and, furthermore, this suppressive effect was independent of numerical depletion of CD4 lymphocytes. Impairment to IL-2-signalling might contribute to the profound impact that HIV has had on both the incidence and the clinicopathological manifestations of TB.

Url:
DOI: 10.1016/S0035-9203(01)90212-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis</title>
<author>
<name sortKey="Lawn, Stephen D" sort="Lawn, Stephen D" uniqKey="Lawn S" first="Stephen D." last="Lawn">Stephen D. Lawn</name>
</author>
<author>
<name sortKey="Rudolph, Donna" sort="Rudolph, Donna" uniqKey="Rudolph D" first="Donna" last="Rudolph">Donna Rudolph</name>
</author>
<author>
<name sortKey="Ackah, Alain" sort="Ackah, Alain" uniqKey="Ackah A" first="Alain" last="Ackah">Alain Ackah</name>
</author>
<author>
<name sortKey="Coulibaly, Doulhourou" sort="Coulibaly, Doulhourou" uniqKey="Coulibaly D" first="Doulhourou" last="Coulibaly">Doulhourou Coulibaly</name>
</author>
<author>
<name sortKey="Wiktor, Stefan" sort="Wiktor, Stefan" uniqKey="Wiktor S" first="Stefan" last="Wiktor">Stefan Wiktor</name>
</author>
<author>
<name sortKey="Lal, Renu B" sort="Lal, Renu B" uniqKey="Lal R" first="Renu B." last="Lal">Renu B. Lal</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D5172770E1E1C71A139CCD6BD60DD381FCF09F1B</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0035-9203(01)90212-3</idno>
<idno type="url">https://api.istex.fr/document/D5172770E1E1C71A139CCD6BD60DD381FCF09F1B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000310</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000310</idno>
<idno type="wicri:Area/Istex/Curation">000310</idno>
<idno type="wicri:Area/Istex/Checkpoint">000618</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000618</idno>
<idno type="wicri:doubleKey">0035-9203:2001:Lawn S:lack:of:induction</idno>
<idno type="wicri:Area/Main/Merge">001156</idno>
<idno type="wicri:Area/Main/Curation">001084</idno>
<idno type="wicri:Area/Main/Exploration">001084</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis</title>
<author>
<name sortKey="Lawn, Stephen D" sort="Lawn, Stephen D" uniqKey="Lawn S" first="Stephen D." last="Lawn">Stephen D. Lawn</name>
<affiliation wicri:level="1">
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Tuberculosis/Mycobacteriology, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333</wicri:regionArea>
<wicri:noRegion>GA 30333</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rudolph, Donna" sort="Rudolph, Donna" uniqKey="Rudolph D" first="Donna" last="Rudolph">Donna Rudolph</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HIV Immunology and Diagnostics Branches, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333</wicri:regionArea>
<wicri:noRegion>GA 30333</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ackah, Alain" sort="Ackah, Alain" uniqKey="Ackah A" first="Alain" last="Ackah">Alain Ackah</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Côte d'Ivoire</country>
<wicri:regionArea>Projet Retro-CI and Centres Antituberculeux, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Coulibaly, Doulhourou" sort="Coulibaly, Doulhourou" uniqKey="Coulibaly D" first="Doulhourou" last="Coulibaly">Doulhourou Coulibaly</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Côte d'Ivoire</country>
<wicri:regionArea>Projet Retro-CI and Centres Antituberculeux, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wiktor, Stefan" sort="Wiktor, Stefan" uniqKey="Wiktor S" first="Stefan" last="Wiktor">Stefan Wiktor</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Côte d'Ivoire</country>
<wicri:regionArea>Projet Retro-CI and Centres Antituberculeux, Abidjan</wicri:regionArea>
<wicri:noRegion>Abidjan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lal, Renu B" sort="Lal, Renu B" uniqKey="Lal R" first="Renu B." last="Lal">Renu B. Lal</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>HIV Immunology and Diagnostics Branches, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333</wicri:regionArea>
<wicri:noRegion>GA 30333</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title>
<title level="j" type="abbrev">TRSTMH</title>
<idno type="ISSN">0035-9203</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">95</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="449">449</biblScope>
<biblScope unit="page" to="452">452</biblScope>
</imprint>
<idno type="ISSN">0035-9203</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0035-9203</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antigen presentation</term>
<term>Antituberculosis treatment</term>
<term>Cohort study</term>
<term>Envelope glycoprotein</term>
<term>Experimental immunology</term>
<term>Functional impairment</term>
<term>Host response</term>
<term>Human immunodeficiency virus</term>
<term>Human immunodeficiency virus type</term>
<term>Human services</term>
<term>Immune</term>
<term>Immune activation</term>
<term>Immune function</term>
<term>Immune response</term>
<term>Immune responses</term>
<term>Immunodeficiency</term>
<term>Impairment</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Lymphocyte</term>
<term>Lymphocyte count</term>
<term>Lymphocyte counts</term>
<term>Median</term>
<term>Median concentration</term>
<term>Median level</term>
<term>National academy</term>
<term>Numerical depletion</term>
<term>Patient groups</term>
<term>Profound impact</term>
<term>Public health service</term>
<term>Pulmonary tuberculosis</term>
<term>Receptor</term>
<term>Serum concentrations</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Significant difference</term>
<term>Soluble</term>
<term>Study participants</term>
<term>Surrogate marker</term>
<term>Tbhiv</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Antigen presentation</term>
<term>Antituberculosis treatment</term>
<term>Cohort study</term>
<term>Envelope glycoprotein</term>
<term>Experimental immunology</term>
<term>Functional impairment</term>
<term>Host response</term>
<term>Human immunodeficiency virus</term>
<term>Human immunodeficiency virus type</term>
<term>Human services</term>
<term>Immune</term>
<term>Immune activation</term>
<term>Immune function</term>
<term>Immune response</term>
<term>Immune responses</term>
<term>Immunodeficiency</term>
<term>Impairment</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Lymphocyte</term>
<term>Lymphocyte count</term>
<term>Lymphocyte counts</term>
<term>Median</term>
<term>Median concentration</term>
<term>Median level</term>
<term>National academy</term>
<term>Numerical depletion</term>
<term>Patient groups</term>
<term>Profound impact</term>
<term>Public health service</term>
<term>Pulmonary tuberculosis</term>
<term>Receptor</term>
<term>Serum concentrations</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Significant difference</term>
<term>Soluble</term>
<term>Study participants</term>
<term>Surrogate marker</term>
<term>Tbhiv</term>
<term>Tropical medicine</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Since expression of both interleukin-2 (IL-2) and IL-2-receptor-α (IL-2R-α) by lymphocytes is inhibited by human immunodeficiency virus (HIV) in vitro, we hypothesized that HIV-co-infection among persons with tuberculosis (TB) might impair T-lymphocyte responses to TB via this mechanism. We measured soluble IL-2R-α (sIL-2R-α), a surrogate marker of T-lymphocyte activation and proliferation, and soluble tumour necrosis factor receptor I (sTNF-RI) in sera from West African patients categorized into 4 groups: those with TB alone (TB+ HIV−, n = 55), CD4-matched groups with TB and HIV co-infection (TB+ HIV+, n = 50) or HIV infection alone (TB− HIV+, n = 35), and patients with neither disease (TB− HIV−, n = 35). The median level of sIL-2R-α was markedly greater in the TB+ HIV− group (1580 U/mL) compared to the TB− HIV− (670 U/mL; P < 0.001) and TB− HIV+ (880 U/mL; P < 0.01) groups. More importantly, the median concentration of sIL-2R-α was much lower in the TB+ HIV+ group (855 U/mL) compared to the TB+ HIV− group (1580 U/mL; P < 0.01) despite similar levels of sTNF-RI. These results suggest that T-lymphocyte activation in TB patients is impaired by HIV co-infection and, furthermore, this suppressive effect was independent of numerical depletion of CD4 lymphocytes. Impairment to IL-2-signalling might contribute to the profound impact that HIV has had on both the incidence and the clinicopathological manifestations of TB.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Côte d'Ivoire</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Lawn, Stephen D" sort="Lawn, Stephen D" uniqKey="Lawn S" first="Stephen D." last="Lawn">Stephen D. Lawn</name>
</noRegion>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Lawn, Stephen D" sort="Lawn, Stephen D" uniqKey="Lawn S" first="Stephen D." last="Lawn">Stephen D. Lawn</name>
</noRegion>
<name sortKey="Lal, Renu B" sort="Lal, Renu B" uniqKey="Lal R" first="Renu B." last="Lal">Renu B. Lal</name>
<name sortKey="Rudolph, Donna" sort="Rudolph, Donna" uniqKey="Rudolph D" first="Donna" last="Rudolph">Donna Rudolph</name>
</country>
<country name="Côte d'Ivoire">
<noRegion>
<name sortKey="Ackah, Alain" sort="Ackah, Alain" uniqKey="Ackah A" first="Alain" last="Ackah">Alain Ackah</name>
</noRegion>
<name sortKey="Coulibaly, Doulhourou" sort="Coulibaly, Doulhourou" uniqKey="Coulibaly D" first="Doulhourou" last="Coulibaly">Doulhourou Coulibaly</name>
<name sortKey="Wiktor, Stefan" sort="Wiktor, Stefan" uniqKey="Wiktor S" first="Stefan" last="Wiktor">Stefan Wiktor</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001084 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001084 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D5172770E1E1C71A139CCD6BD60DD381FCF09F1B
   |texte=   Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024